Patents Assigned to N.V. Nutricia
-
Patent number: 11918546Abstract: The invention pertains to the use of therapeutically effective amounts of (a) (i) vitamin C and/or selenium and (ii) at least one of docosahexaenoic acid (22:6; DHA), eicosapentaenoic acid (20:5; EPA) and docosapentaenoic acid (22:5; DPA), or esters thereof; or (b) (i) vitamin C and/or selenium and (iii) one or more of uridine and cytidine, or salts, phosphates, acyl derivatives or esters thereof; or (c) a combination of (i), (ii) and (iii); wherein (a), (b) or (c) optionally further comprises vitamin E, in the manufacture of a product for therapeutically improving synaptic connectivity and/or therapeutically supporting memory and/or cognitive function in a human subject in need thereofType: GrantFiled: August 11, 2021Date of Patent: March 5, 2024Assignee: N.V. NutriciaInventor: Mattheus Cornelis de Wilde
-
Publication number: 20240057626Abstract: The present invention provides a process of producing a lactose concentrate, said process comprising the step of subjecting a partially demineralised aqueous lactose isolate to electrodialysis to produce a biotin-reduced lactose isolate containing at least 90% lactose by weight of dry matter and less than 2 mg ash per gram of lactose, and containing: 0.02-1.5 mg sodium per gram of lactose; 0.02-2 mg potassium per gram of lactose; 0.05-1.5 mg chloride per gram of lactose; 0.01-0.25 ?g biotin per gram of lactose. The present invention also relates to a demineralised lactose concentrate having a reduced biotin content that can be produced by the aforementioned process. The invention further relates to an oligosaccharide-enriched biotin-reduced fraction that is obtained when lactose is separated before or after the electrodialysis step.Type: ApplicationFiled: December 31, 2021Publication date: February 22, 2024Applicant: N.V. NutriciaInventors: Cameron Marshall, Tuan Nguyen, Ana Ospina Martinez
-
Publication number: 20240058373Abstract: The invention relates to a fibre mixture comprising beta-galactooligosaccharides, inulin, resistant starch and soluble soy polysaccharides and to nutritional compositions comprising such a fibre mixture. The intended use of the fibre mixture and nutritional compositions is for preventing or treating constipation, especially in young children.Type: ApplicationFiled: December 9, 2021Publication date: February 22, 2024Applicant: N.V. NutriciaInventors: Houkje BOURITIUS, Sebastian TIMS
-
Publication number: 20230380438Abstract: The invention concerns a native whey protein composition with profound amounts of native whey protein and with beta-casein for use in the treatment and/or prevention of gastrointestinal intolerance. The inventors found that the native whey protein composition relatively high in beta-casein and low in kappa- and alpha-casein provides a beneficial effect on gastrointestinal intolerance.Type: ApplicationFiled: October 27, 2021Publication date: November 30, 2023Applicant: N.V. NutriciaInventors: Ingrid Brunhilde Renes, Evan Abrahamse, Gerrit Hols
-
Patent number: 11790378Abstract: Method for providing a container with food, the method comprising: providing a container for infant formula food, adding the food, sealing the container with a gas-tight membrane seal, adding an inner scannable code on the gas-tight membrane seal, closing the container with a tamper-proof closure means, so that the inner scannable code is not scannable without breaking a part of the tamper-proof closure means, and storing the inner scannable code in a database.Type: GrantFiled: December 21, 2022Date of Patent: October 17, 2023Assignee: N.V. NutriciaInventor: Elmar Martin Fischbach
-
Publication number: 20230293567Abstract: The invention pertains to the use of soluble sodium in the manufacture of a composition or kit of parts for (therapeutically) improving and prolonging blood plasma uridine levels and tissue availability of uridine, and/or for treating or preventing impaired blood plasma uridine levels and tissue availability of uridine, and/or for preventing/treating disorders associated with impaired blood plasma and tissue availability of uridine, in a mammal, preferably a human being, by orally co-administering soluble sodium and uridine in a molar ratio of soluble sodium to uridine of more than 1:1, preferably more than 1.5:1, more preferably more than 2:1, even more preferably at least 2.5:1, even more preferably at least 2.8:1, more preferably 3:1-15:1, most preferably 3:1-10:1, particularly 3:1-5:1.Type: ApplicationFiled: May 24, 2023Publication date: September 21, 2023Applicant: N.V. NutriciaInventor: Robert Johan Joseph Hageman
-
Patent number: 11707080Abstract: The present invention relates to formulae for infants born via Caesarean section for improving the postnatal growth trajectory or body development.Type: GrantFiled: December 4, 2020Date of Patent: July 25, 2023Assignee: N.V. NutriciaInventors: Stefanie Schoen, Dennis Stanley Acton
-
Patent number: 11707079Abstract: The present invention concerns a process for manufacturing an infant formula product comprising: (a1) providing an aqueous mixture having a protein component and a carbohydrate component, (a2) subjecting the aqueous mixture to a protein hydrolysis step, (a3) subjecting the aqueous mixture to a heat treatment step; (b) mixing the heat-treated aqueous mixture comprising hydrolyzed protein with a lipid component; (c) subjecting the aqueous mixture comprising the lipid component, the carbohydrate component and the heat-treated hydrolyzed protein component to a homogenization and emulsification step to obtain a homogenized oil-in-water emulsion having a total solids content in the range of 45-80 wt %; (d) conveying the homogenized emulsion into an extruder, independently adding digestible carbohydrates and optionally dietary fibres to the extruder and extruding the contents of the extruder to obtain an extruded material; (e) preparing an infant formula product from the extruded material.Type: GrantFiled: June 13, 2019Date of Patent: July 25, 2023Assignee: N.V. NutriciaInventors: Memet Ali Üstünel, Katerina Jezkova, Susana Pedraza de la Cuesta
-
Patent number: 11707478Abstract: The invention pertains to the use of soluble sodium in the manufacture of a composition or kit of parts for (therapeutically) improving and prolonging blood plasma uridine levels and tissue availability of uridine, and/or for treating or preventing impaired blood plasma uridine levels and tissue availability of uridine, and/or for preventing/treating disorders associated with impaired blood plasma and tissue availability of uridine, in a mammal, preferably a human being, by orally co-administering soluble sodium and uridine in a molar ratio of soluble sodium to uridine of more than 1:1, preferably more than 1.5:1, more preferably more than 2:1, even more preferably at least 2.5:1, even more preferably at least 2.8:1, more preferably 3:1-15:1, most preferably 3:1-10:1, particularly 3:1-5:1.Type: GrantFiled: August 23, 2017Date of Patent: July 25, 2023Assignee: N.V. NutriciaInventor: Robert Johan Joseph Hageman
-
Publication number: 20230189854Abstract: The present invention concerns a process for producing a dry cereal composition, comprising (a) fermenting phytic acid containing cereals by phytase-positive lactic acid bacteria at a temperature below 45° C., until a pH of at most 5.9 is reached, (b) heating the fermented cereals obtained in step (a) to a temperature in the range of 40-55° C., for a period of at least 1.5 h; (c) drying the fermented and phytase treated cereals originating from step (b) to obtain the dry cereal composition. The present invention is ideally suited to reduce the phytate content of fermented cereals, thereby increasing the bio-availability of minerals. The invention further contains the dry cereal composition obtainable by the process according to the invention, especially having a molar ratio of phytate to iron of at most 1, and the use thereof in increasing the bio-availability of minerals.Type: ApplicationFiled: May 25, 2021Publication date: June 22, 2023Applicant: N.V. NutriciaInventors: Ana Catarina da Silva Pereira, Camilla Linhart, Hans Thomas Moes, Bastiaan Schouten, Raphaëlle Sicard épouse Bourdet, Audrey Boniface épouse Guiraud
-
Patent number: 11641868Abstract: The invention relates to improved liver health and lipid metabolism later in life upon ingestion of synbiotics early in life.Type: GrantFiled: December 30, 2019Date of Patent: May 9, 2023Assignee: N.V. NutriciaInventors: Eefje Engels, Cornelus Johannes Petrus Van Limpt, Annemarie Oosting, Akhtar Raish Oozeer, Jan Knol, Mona Mischke
-
Patent number: 11638729Abstract: The invention relates to prevention of insulin resistance or low-grade chronic inflammation later in life upon ingestion of synbiotics early in life.Type: GrantFiled: December 30, 2019Date of Patent: May 2, 2023Assignee: N.V. NutriciaInventors: Eefje Engels, Cornelus Johannes Petrus Van Limpt, Annemarie Oosting, Akhtar Raish Oozeer, Jan Knol, Mona Mischke
-
Patent number: 11638438Abstract: The invention relates to improved liver health and lipid metabolism later in life upon ingestion of synbiotics early in life.Type: GrantFiled: December 30, 2019Date of Patent: May 2, 2023Assignee: N.V. NutriciaInventors: Eefje Engels, Cornelus Johannes Petrus Van Limpt, Annemarie Oosting, Akhtar Raish Oozeer, Jan Knol, Mona Mischke
-
Publication number: 20230127113Abstract: Method for providing a container with food, the method comprising: providing a container for infant formula food, adding the food, sealing the container with a gas-tight membrane seal, adding an inner scannable code on the gas-tight membrane seal, closing the container with a tamper-proof closure means, so that the inner scannable code is not scannable without breaking a part of the tamper-proof closure means, and storing the inner scannable code in a database.Type: ApplicationFiled: December 21, 2022Publication date: April 27, 2023Applicant: N.V. NutriciaInventor: Elmar Martin Fischbach
-
Patent number: 11632974Abstract: An early in life nutritional intervention with a lipid component having both large lipid globules with phospholipids and an increased amount of palmitic acid in the sn-2 position in triglycerides were found to improve the fatty acid composition of cell membranes, in particular brain membranes.Type: GrantFiled: June 7, 2019Date of Patent: April 25, 2023Assignee: N.V. NutriciaInventors: Anniek Lidewij Schipper, Eline Marleen Van Der Beek, Dennis Stanley Acton, Nana Bartke, Stefanie Schoen
-
Patent number: 11596167Abstract: The present invention relates to infant formulas and follow-on formulas containing optimised amino acid profiles, in particular optimised amounts and/or ratios of phenylalanine. The formulas may contain intact proteins, hydrolysed proteins, protein fractions, free amino acids and/or a combination thereof selected based on their ability to provide the formula with an optimised amino acid profile. The present invention also relates to the administration of these formulas to infants in order to achieve balanced growth and/or development, for promoting, assisting or achieving balanced growth or development of the brain of an infant and/or the cognitive function of an infant, and may also assist in preventing or reducing the risk of obesity later in life.Type: GrantFiled: May 19, 2014Date of Patent: March 7, 2023Assignee: N.V. NutriciaInventors: Eline Marleen Van Der Beek, Marieke Abrahamse-Berkeveld, Johannes Bernard Van Goudoever
-
Publication number: 20230068996Abstract: The present invention relates to anti-regurgitation formula with locust bean gum and non-digestible oligosaccharides for improved effect on functional gastro-intestinal disorders in infants and young children.Type: ApplicationFiled: January 28, 2021Publication date: March 2, 2023Applicant: N.V. NutriciaInventors: Akhtar Raish Oozeer, Emilie Celine Rocher
-
Publication number: 20230046623Abstract: The invention concerns nutritional compositions comprising lipid globules that are larger than conventional and comprise a coating comprising milk derived phospholipids that have a beneficial effect on gut maturation.Type: ApplicationFiled: February 1, 2021Publication date: February 16, 2023Applicant: N.V. NutriciaInventors: Mona Mischke, Ingrid Brunhilde Renes, Isabelle van Seuningen, Audrey Vincent
-
Patent number: 11559539Abstract: The invention concerns the use of fucosylated non-digestible human milk oligosaccharide, or a composition comprising a fucosylated non-digestible human milk oligosaccharide, for use in improving immune fitness in a human subject, wherein the human subject is male.Type: GrantFiled: February 10, 2020Date of Patent: January 24, 2023Assignee: N.V. NutriciaInventors: Belinda Potappel-Van 'T Land, Lieke Wilhelmina Johanna Van Den Elsen, Bernd Stahl
-
Patent number: 11556939Abstract: Method for providing a container with food, the method comprising: providing a container for infant formula food, adding the food, sealing the container with a gas-tight membrane seal, adding an inner scannable code on the gas-tight membrane seal, closing the container with a tamper-proof closure means, so that the inner scannable code is not scannable without breaking a part of the tamper-proof closure means, and storing the inner scannable code in a database.Type: GrantFiled: December 18, 2018Date of Patent: January 17, 2023Assignee: N.V. NutriciaInventor: Elmar Martin Fischbach